COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 2062: Articles 20611-20620  | Next

What is the efficacy and safety of rapid exercise tests for exertional desaturation in Covid-19: A rapid review protocol
kalin, A., Greenhalgh, T., Javid, B., Knight, M., Inada-Kim, M.
10.1101/2020.10.31.20223453 — Posted: 2020-11-04
Modelling and Forecasting The Number of Confirmed Cases and Deaths from COVID-19 Pandemic in USA from April 12th to May 21st, 2020
Jamshidi, B., Jamshidi Zargaran, S., Talaei-Khoei, A., Kakavandi, M.
10.1101/2020.10.30.20223412 — Posted: 2020-11-04
A Two-Region SEIR COVID-19 Epidemic Model for the Island of Ireland
Grannell, J. J., Grannell, J. R.
10.1101/2020.10.31.20223727 — Posted: 2020-11-04
Forecasting new daily confirmed cases infected by COVID-19 in Italy from April 9th to May 18th 2020
Jamshidi, B., Talaei-Khoei, A., Jamshidi Zargaran, S., Rezaei, M.
10.1101/2020.10.30.20223222 — Posted: 2020-11-04
SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate among the Non-Congregant Population in Connecticut
Mahajan, S., Caraballo, C., Li, S.-X., Dong, C., Chen, L., Huston, S. K., Srinivasan, R., Redlich, C. A., Ko, A. I., Faust, J. S., Forman, H. P., Krumholz, H. M.
10.1101/2020.10.30.20223461 — Posted: 2020-11-04
RAPPID: a platform of ratiometric bioluminescent sensors for homogeneous immunoassays
Ni, Y., Rosier, B. J. H. M., van Aalen, E. A., Hanckmann, E. T. L., Biewenga, L., Makri Pistikou, A.-M., Timmermans, B., Vu, C., Roos, S., Arts, R., Li, W., de Greef, T. F. A., van Kuppeveld, F. J. M., Bosch, B.-J., Merkx, M.
10.1101/2020.10.31.363044 — Posted: 2020-11-03
Early immune response in mice immunized with a semi-split inactivated vaccine against SARS-CoV-2 containing S protein-free particles and subunit S protein
Petras, M., Lesny, P., Musil, J., Limberkova, R., Patikova, A., Jirsa, M., Krsek, D., Brezovsky, P., Koladiya, A., Vanikova, S., Mackova, B., Jirova, D., Krijt, M., Lesna, I. K., Adamkova, V.
10.1101/2020.11.03.366641 — Posted: 2020-11-03 Discussion: Onsite
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
Hattori, T., Koide, A., Panchenko, T., Romero, L. A., Teng, K. W., Tada, T., Landau, N. R., Koide, S.
10.1101/2020.11.03.365270 — Posted: 2020-11-03 Discussion: Offsite
Looking for pathways related to COVID-19 phenotypes: Confirmation of pathogenic mechanisms by SARS-CoV-2 - Host interactome.
Messina, F., Giombini, E., Montaldo, C., Sharma, A. A., Piacentini, M., Zoccoli, A., Sekaly, R. P., Locatelli, F., Zumla, A., Maeurer, M., Capobianchi, M. R., Lauria, F. N., Ippolito, G.
10.1101/2020.11.03.366666 — Posted: 2020-11-03
Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus
Gopal, V., Nilsson-Payant, B. E., French, H., tenOever, B., Yung, W.-s., Hardwick, M., te Velthuis, A.
10.1101/2020.11.02.365833 — Posted: 2020-11-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).